Ministry of Health announced: Volunteers wanted for Kovid-19 vaccine
In a statement from the Ministry of Health, originating in China started to phase-3 study in Turkey to volunteer citizens previously Kovid-19 passing for coronavirus vaccine was asked.
According to the statement made by the Ministry of Health, citizens between the ages of 18-59, who have not had Kovid-19 before, can volunteer by calling "https://covid19asi.calismasi.info" or by calling 0850 811 18 80.
Kovid-19 vaccine applications, continues at 25 centers in 12 cities in Turkey. The vaccine, which was first introduced on high-risk healthcare workers, has been administered on 726 volunteer healthcare workers to date, and 1237 doses of vaccine have been administered. Since the safety data of the applications in the healthcare professionals group were evaluated positively, the applications were opened to normal risky citizens.
In the ongoing stages of vaccination, interim evaluation reports are prepared for every 500 volunteers. According to the interim safety report prepared with 518 people on November 6, the vaccine had no significant side effects. The most common side effects were reported as fatigue (7.5 percent), headache (3.5 percent), muscle pain (3 percent), fever (3 percent) and injection site pain (2.5 percent). Independent data monitoring committee stated that they had no reservations about the safety of the vaccine in evaluating the interim safety report with the data available.
PLANNED TO HAVE OVER 12 THOUSAND 450 VOLUNTEERS
Vaccination; It continues in two stages as high risk healthcare workers and normal risk volunteers. The Kovid-19 vaccine is planned to be applied on 12 thousand 450 volunteers in total.
In the vaccine study, some of the volunteers are given the actual vaccine and the other part is given a placebo. This method is randomly determined by the computer program, and the research team does not know what was done to which volunteer.
In the trials to be carried out on volunteer citizens, 2 out of every 3 people will be given a real vaccine. In this way, the difference in effect between the real vaccine and the non-vaccine will be revealed. At the end of the study, all volunteers in the placebo arm will be invited back to the centers and the actual vaccination will be administered.